Johnson & Johnson JNJ
271.22
0.54
0.20%
as of 25 Sep
- Market cap
- $652.8B
- P/E
- 31.4×
Follow JNJ
S&P 500 Member
Dividend Aristocrat
Cash Flow Champion (3y)
Revenue Champion (3y)
Insider Buys (last 12m)
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
Johnson & Johnson (JNJ) Gross margin
Johnson & Johnson's gross margin over the twelve months to 30 June 2026 was 67.9%, up 0.0 percentage points from fiscal 2025 (67.9%). Over the past ten years it has ranged from 65.6% (fiscal 2020) to 70.3% (fiscal 2021); the current reading is higher than 45% of that period. That is below the Drug Manufacturers General industry median of 72.8% and above the Healthcare sector median of 53.7%.
Gross margin, annual
Annual
| Period | Gross margin | Change (points) |
|---|---|---|
| FY2025 | 67.9% | (1.19) |
| FY2024 | 69.1% | 0.25 |
| FY2023 | 68.8% | (0.43) |
| FY2022 | 69.3% | (1.03) |
| FY2021 | 70.3% | 4.70 |
| FY2020 | 65.6% | (0.84) |
| FY2019 | 66.4% | (0.37) |
| FY2018 | 66.8% | 0.07 |
| FY2017 | 66.7% | (2.97) |
| FY2016 | 69.7% | 0.42 |
Quarterly
| Period | Gross margin | Change (points) |
|---|---|---|
| Jun 2026 | 68.2% | 1.88 |
| Mar 2026 | 66.3% | (1.25) |
| Dec 2025 | 67.6% | (2.00) |
| Sep 2025 | 69.6% | 1.69 |
| 42 more quarters | Free account |
Against its own ten years
Low 65.6%
High 70.3%
Ten-year median
68.8%
Current reading's percentile
45
Gross margin against peers
| Company | Gross margin |
|---|---|
| LLY Eli Lilly and Company compare | 83.4% |
| AZN AstraZeneca PLC compare | 81.9% |
| GILD Gilead Sciences, Inc. compare | 79.6% |
| NVS Novartis AG compare | 74.7% |
| PFE Pfizer Inc. compare | 73.2% |
| MRK Merck & Co., Inc. compare | 73.0% |
| ABBV AbbVie Inc. compare | 71.5% |
| AMGN Amgen Inc. compare | 69.5% |
| JNJ Johnson & Johnson | 67.9% |
| Drug Manufacturers General industry median | 72.8% |
| Healthcare sector median | 53.7% |
| Market median | 46.3% |
What Gross margin is
Gross Margin tells an investor how much of each sale a company keeps after paying the direct costs of making or buying what it sells.
Gross Profit ÷ Revenue
More on JNJ
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement